A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Clinical trial NCT06989437 · RECRUITING

Trial details

NCT number: NCT06989437
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cachexia Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2025-10-03
Primary completion: 2028-01-17
Enrollment: 982

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.